Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9D72

CryoEM structure of anti-MHC-I Fab M1/42 complex with H2-Dd

9D72 の概要
エントリーDOI10.2210/pdb9d72/pdb
関連するPDBエントリー8TQ4
EMDBエントリー46600
分子名称Beta-2-microglobulin, Fab M1/42 Light Chain, Surface protein gp120, ... (5 entities in total)
機能のキーワードmhc-i, anti-mouse-mab, h2-dd, m1/42, anti-mhc-i antibody, anti-tumor, cancer immunotherapy, antitumor protein, antitumor protein-immune system complex, antitumor protein/immune system
由来する生物種Mus musculus (house mouse)
詳細
タンパク質・核酸の鎖数5
化学式量合計91734.50
構造登録者
Jiang, J.,Natarajan, K.,Margulies, D.H.,Lei, H.,Huang, R. (登録日: 2024-08-16, 公開日: 2026-02-04, 最終更新日: 2026-05-13)
主引用文献Jiang, J.,Panda, A.K.,Natarajan, K.,Lei, H.,Sharma, S.,Boyd, L.F.,Towler, R.R.,Chempati, S.,Ahmad, J.,Morton, A.J.,Lang, Z.C.,Sun, Y.,Sgourakis, N.,Meier-Schellersheim, M.,Huang, R.K.,Shevach, E.M.,Margulies, D.H.
Structural mechanism of anti-MHC-I antibody blocking of inhibitory NK cell receptors in tumor immunity.
Res Sq, 2025
Cited by
PubMed Abstract: Anti-major histocompatibility complex class I (MHC-I) mAbs can stimulate immune responses to tumors and infections by blocking suppressive signals delivered via various immune inhibitory receptors. To understand such functions, we determined the structure of a highly cross-reactive anti-human MHC-I mAb, B1.23.2, in complex with the MHC-I molecule HLA-B*44:05 by both cryo-electron microscopy (cryo-EM) and X-ray crystallography. Structural models determined by the two methods were essentially identical revealing that B1.23.2 binds a conserved region on the α2 helix that overlaps the killer immunoglobulin-like receptor (KIR) binding site. Structural comparison to KIR/HLA complexes reveals a mechanism by which B1.23.2 blocks inhibitory receptor interactions, leading to natural killer (NK) cell activation. B1.23.2 treatment of the human KLM-1 pancreatic cancer model in humanized (NSG-IL15) mice provides evidence of suppression of tumor growth. Such anti-MHC-I mAb that block inhibitory KIR/HLA interactions may prove useful for tumor immunotherapy.
PubMed: 41333432
DOI: 10.21203/rs.3.rs-7133881/v1
主引用文献が同じPDBエントリー
実験手法
ELECTRON MICROSCOPY (2.67 Å)
構造検証レポート
Validation report summary of 9d72
検証レポート(詳細版)ダウンロードをダウンロード

255900

件を2026-07-01に公開中

PDB statisticsPDBj update infoContact PDBjnumon